Earlier, myotrophin, a factor, has been isolated, purified, and partia
lly sequenced from spontaneously hypertensive rat hearts that stimulat
ed myocyte growth. To evaluate the role of myotrophin in the initiatio
n of the human dilated cardiomyopathic heart, we have isolated and pur
ified myotrophin to homogeneity (approximately 50 000-fold) as defined
by reverse-phase high-performance liquid chromatography and sodium do
decyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). During pu
rification, we used a bioassay system in which adult myocardial cells
maintained in culture were used to evaluate protein synthesis by the i
ncorporation of [H-3]leucine into myocyte protein. Myotrophin purified
from human dilated cardiomyopathic hearts is composed of a single pol
ypeptide chain having an apparent molecular mass of 12 kD, determined
by SDS-PAGE. The partial internal amino acid sequence of human myotrop
hin is very similar to that of rat myotrophin peptide T9. Using a rat
myotrophin peptide (T26) antibody, we identified human myotrophin on a
n immunoblot. These results showed that human myotrophin possesses the
T9 and T26 regions of rat myotrophin. Human myotrophin stimulated myo
cardial protein synthesis and cell growth, similar to the way in which
rat myotrophin stimulated these factors. Western blot analysis showed
the presence of myotrophin in both dilated cardiomyopathic and normal
human hearts. In addition, we observed significantly elevated levels
of myotrophin in dilated cardiomyopathic human hearts when compared wi
th age- and sex-matched normal control hearts. From these observations
, we conclude that myotrophin is present in normal human hearts, is fo
und at higher levels in dilated cardiomyopathic human hearts, and may
play a role in the initiation of cardiac hypertrophy as well as in nor
mal growth of cardiac myocytes in humans.